January 2025
1. LI P
   Risankizumab for Ulcerative Colitis.
   JAMA. 2025 Jan 22. doi: 10.1001/jama.2024.25640.
   

   >> Share

   
   
2. LOUIS E, Kalabic J, Loftus EV Jr
   Risankizumab for Ulcerative Colitis-Reply.
   JAMA. 2025 Jan 22. doi: 10.1001/jama.2024.25643.
   

   >> Share

   
   October 2024
3. VESTERGAARD MV, Nohr AK, Allin KH, Krarup H, et al
   HLA-DRB1*01:03 and Severe Ulcerative Colitis.
   JAMA. 2024 Oct 15:e2420429. doi: 10.1001/jama.2024.20429.
   

   >> Share

   
   July 2024
4. LOUIS E, Schreiber S, Panaccione R, Bossuyt P, et al
   Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
   JAMA. 2024 Jul 22:e2412414. doi: 10.1001/jama.2024.12414.
   

   >> Share

   
   
5. KAPLAN GG
   Monoclonal Antibody Risankizumab for Ulcerative Colitis.
   JAMA. 2024 Jul 22. doi: 10.1001/jama.2024.8819.
   

   >> Share

   
   February 2024
6. VOELKER R
   What Is Ulcerative Colitis?
   JAMA. 2024 Feb 2. doi: 10.1001/jama.2023.23814.
   

   >> Share

   
   November 2023
7. SURAN M
   Highlights From Gastroenterology Week: New Crohn Disease Drug, Redefining Liver Disease, and More.
   JAMA. 2023 Nov 2. doi: 10.1001/jama.2023.19140.
   

   >> Share

   
   September 2023
8. GROS B, Kaplan GG
   Ulcerative Colitis in Adults: A Review.
   JAMA. 2023;330:951-965.
   

   >> Share

   
   March 2023
9. HARRIS E
   Patients With Normal Gut Biopsy Still at Increased Risk of IBD.
   JAMA. 2023;329:875.
   

   >> Share

   
   
10. ZHANG S, Chen B, Wang B, Chen H, et al
    Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis: A Randomized Clinical Trial.
    JAMA. 2023;329:725-734.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share